Computational protocol may one day enable drug developers to craft novel, therapeutic peptides that precisely target specific disease-causing molecules within the body
Users can run experiments on an IBM quantum processor
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.